Lawrence Monoson, CEO - RxData LUNSUMIO (mosunetuzumab): A Favorable Access Decision in Contrast to the United Kingdom ...
Overheard at ISPOR: IRA Drug Price Negotiations The 2022 Inflation Reduction Act, which aims to contain Medicare spending and improve affordability of drugs costs, was a hot topic at the recent ISPOR (International Society for Pharmac...
Purchase the book here The RxData team is thrilled to be a part of the World Evidence, Pricing and Access Congress in Amsterdam. A lot of great lec...
{{IMAGE1}} Ian Judson is a prolific early stage investor and the Founder and Managing Partner of Valence Ventures . He brings over 15 years of experience in technology and healthcare as an operator and an investor. Prior to starting Valence, I...
On December 15th, CMS announced that the Administration will not implement the proposed Medicare Part B drug payment model. Since being proposed in March 2016, the demonstration was opposed by certain industry groups, and was criticized by Congressio...
In reponse to the IMS Institute for Healthcare Informatics September 2016 report titled “Comparison of Hepatitis C Treatment Costs” and FiercePharma’s follow-up article “Surprise: Gilead's hep C wonder Harvoni costs less in U.S. than in EU, Japan”...
Come talk to us at the AMCP Annual Meeting from the 19th to the 22nd of April! The AMCP Managed Care & Specialty Pharmacy Annual Meeting is still the only event that brings together all the voices and visions of managed care pharmacy, health care, an...
RxData and CEO Lawrence Monoson were featured on French television channel BFM-TV. The interview was broadcast on February 13th and 14th on TV and radio channels. The video below includes English subtitles. <iframe width="560" height="315" src="ht...
RxData hired three summer interns with diverse backgrounds including biological sciences, economics, and mathematics/programming. All contribute to growing the company while simultaneously benefiting from their experience within the health-tech start...
Following RxData’s expansion into Switzerland, Lawrence Monoson was nominated as one of Switzerland’s top innovators by l’Hebdo, a Swiss magazine with more than 166,000 readers. The article refers to RxData as the “Bloomberg for Pharma”, nickname tha...
{{IMAGE1}} Jeffrey A. Sachs is a leading health care policy expert who has worked with federal and state governments, hospitals, health systems, health plans, behavioral health organizations, technology companies, unions and others for more th...
RxData gets a booth at ISPOR, one of the major global market access conferences. The conference, held in Milan, hosted over 5220 attendees from 90 countries. Our own CEO, Lawrence Monoson, showcased RxData’s capabilities and met with prospective clie...
RxData has been awarded the Innovator of the Year award by PM360. The specialized review highlights forward-thinkers in their third annual Innovations in Pharma Marketing special issue and provide a guide to the Companies, Divisions, Products, People...
Blueprint Health, a NYC based mentor-focused health technology accelerator today announced the showcase of their Summer 2014 class of startups at their sixth annual Demo Day in NYC. The Summer 2014 Accelerator class is composed of seven new companies...